Interestingly we found that CDKN2A,FADD,GATA3,MYC were highly variable between gain and loss in CNV, while at the mRNA expression level these same NRGS were also found to be significantly different in normal tissues compared to tumor tissues. This evidence concerns the gene CDKN2A and neoplasm.